Filing Details
- Accession Number:
- 0001209191-23-054194
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-02 17:16:26
- Reporting Period:
- 2023-11-02
- Accepted Time:
- 2023-11-02 17:16:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818794 | Dyne Therapeutics Inc. | DYN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1691005 | Gatti Susanna High | C/O Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham MA 02451 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-02 | 9,939 | $7.40 | 94,605 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 10, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $7.12 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
Billionaire Hedge Funds
